Regulation of class II MHC expression

Critical Reviews in Immunology

Volumn 16, Issue 3, 1996, Pages 311-330

  Rohn, Wolfgang M ^a   Lee, Yi Ju ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

antigen presentation; autoimmunity; CIITA; cytokines; signal transduction; transcription factors

Indexed keywords

CIS ACTING ELEMENT; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHORBOL ESTER; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; COMBINED IMMUNODEFICIENCY; GENE INSERTION; HELPER CELL; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; PROMOTER REGIONS (GENETICS); PROTEINS;

EID: 0029914163     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (172)

1. Benacerraf, B., Role of MHC gene products in immune regulation, Science, 212, 1229, 1981.
2. Rothenberg, E. V., Signaling mechanisms in thymocyte selection, Current Opin. Immunol., 6, 257, 1994
3. Grusby, M. J. and Glimcher, L. H., Immune responses in MHC class II-deficient mice, Annu. Rev. Immunol., 13, 417. 1995.
4. Mach, B., Steimle, V., and Reith, W., MHC class II-deficient combined immunodeficiency: a disease of gene regulation, ImmunoL Rev., 138, 207, 1994.
5. Ting, J. P.-Y. and Baldwin, A. S., Regulation of MHC gene expression, Current Opin. Immunol., 5, 8, 1993.
6. Steimle, V., Otten, L. A., Zufferey, M., and Mach, B., Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome), Cell, 75, 135, 1993.
7. Glimcher, L. H. and Kara, C. J., Sequences and factors: a guide to MHC class II transcription, Annu. Rev. Immunol., 10, 13, 1992.
8. Silacci, P., Mottet, A., Steimle, V., Reith, W., and Mach, B., Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA, J. Exp. Med., 180, 1329, 1994.
9. Noelle, R. J., Kuziel, W. A., Maliszewski, C. R., McAdams, E., Vitetta, E. S., and Tucker, P. W., Regulation of the expression of multiple class II genes in murine B cells by B cell stimulatory factor-1 (BSF-1), J. Immunol., 137, 1718, 1986.
10. Monroe, J. G. and Cambier, J. C., B cell activation. III. B cell plasma membrane depolarization and hype-Ia antigen expression induced by receptor immunoglobulin cross-linking are coupled, J. Exp. Med., 158, 1489, 1983.
11. Mond, J. J., Seghal, E., Kung, J., and Finkelman, F. D., Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin, J. Immunol., 127, 881, 1981.
12. Monroe, J. G., Niedel, J. E., and Cambier, J. C., B cell activation. IV. Induction of cell membrane depolarization and hyper-Ia expression by phorbol diesters suggests a role for protein kinase C in murine B lymphocyte activation, J. Immunol., 132, 1472, 1984.
13. Mond, J. J., Carman, J., Sarma, C., Ohara, J., and Finkelman, F. D., Interferon-γ suppresses B cell stimulation factor (BSF-1 ) induction of class II MHC determinants on B cells, J. Immunol., 137, 3534, 1986.
14. 2 inhibits B lymphocyte activation by a cAMP-dependent mechanism: PGE-inducible regulatory proteins, Cell. Immunol., 154, 296, 1994
15. McMillan, V. M., Dennis, G. J., Glimcher, L. H., Finkelman, F. D., and Mond, J. J., Corticosteroid induction of Ig+ Ia- B cells in vitro is mediated via interaction with the glucocorticoid cytoplasmic receptor, J. Immunol., 140, 2549, 1988.
16. Celada, A., McKercher, S., and Maki, R. A., Repression of major histocompatibility complex IA expression by glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein, J. Exp. Med., 177, 691, 1993.
17. Schwiebert, L. M., Schleimer, R. P., Radka, S. F., and Ono, S. J., Modulation of MHC class II expression in human cells by dexamethasone, Cell. Immunol., 165, 12, 1995.
18. Wekerle, H., Antigen presentation by central nervous system glia, in Neuroglia, Kettenmann, H. and Ransom, B. R., Eds., Oxford Press, 1995, 685.
19. Calder, V. L., Wolswijk, G., and Noble, M., The differentiation of 0-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens, Eur. J. Immunol., 18, 1195, 1988.
20. Kingston, A. E., Bergsteinsdottir, K., Jessen, K. R., van der Meide, P. H., Colston, M. J., and Mirsky, R., Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-γ pretreatment: synergistic effects of interferon-γ and tumor necrosis factor on MHC class II induction, Eur. J. Immunol., 19, 177, 1989.
21. Vidovic, M., Sparacio, S. M., Elovitz, M., and Benveniste, E. N., Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α, J. Neuroimmunol., 30, 189, 1990.
22. Böttger, E. C., Blanar, M. A., and Flavell, R. A., Cycloheximide, an inhibitor of protein synthesis, prevents γ-interferon-induced expression of class II mRNA in a macrophage cell line, Immunogenetics, 28, 215, 1988.
23. Fertsch, D., Schoenberg, D. R., Germain, R. N., Tou, J. Y. L., and Vogel, S. N., Induction of macrophage Ia antigen expression by rIFN-γ and down-regulation by IFN-α/β and dexamethasone are mediated by changes in steady-state levels of Ia mRNA, J. Immunol., 139, 244, 1987.
24. Lee, Y.-J. and Benveniste, E. N., STAT-1α expression is involved in IFN-γ induction of the CIITA and class II MHC genes, J. Immunol., 157, 1559, 1996.
25. Politis, A. D. and Vogel, S. N., Pharmacologic evidence for the requirement of protein kinase C in IFN-induced macrophage Fcγ receptor and Ia antigen expression, J. Immunol., 145, 3788, 1990.
26. + entry, J. Biol. Chem., 266, 18119, 1991.
27. Lee, Y.-J., Panek, R. B., Huston, M., and Benveniste, E. N., Role of protein kinase C and tyrosine kinase activity in IFN-γ induced expression of the class II MHC gene, Am. J. Physiol.: Cell Physiol., 37, 127, 1995.
28. Fan, X.-D., Goldberg, M., and Bloom, B. R., Interferon-γ-induced transcriptional activation is mediated by protein kinase C, Proc. Natl. Acad. Sci. U.S.A., 85, 5122, 1988.
29. Ryu, K., Koide, Y., Yamashita, Y., and Yoshida, T. O., Inhibition of tyrosine phosphorylation prevents IFN-γ-induced HLA-DR molecule expression, J. Immunol., 150, 1253, 1993.
30. Brown, D., Faris, M., Hilburger, M., and Zwilling, B. S., The induction of persistence of I-A expression by macrophages from Beg mice occurs via a protein kinase C-dependent pathway, J. Immunol., 152, 1323, 1994.
31. 2+-calmodulin complex are involved in interferon-γ-induced expression of HLA class II molecules on HL-60 cells, Proc. Natl. Acad. Sci. U.S.A., 85, 3120, 1988.
32. Celada, A. and Maki, R. A., IFN-γ-induces the expression of the genes for MHC class II I-Aβ and tumor necrosis factor through a protein kinase C-independent pathway, J. Immunol., 146, 114, 1991.
33. β genes, Science, 244, 469, 1989.
34. + exchange in astrocytes, J. Biol. Chem., 269, 13811, 1994.
35. Darnell, J. E. Jr., Kerr, I. M., and Stark, G. R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science, 264, 1415, 1994.
36. Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E. Jr., Stark, G. R., and Kerr, I. M., Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathway, EMBO J., 12, 4221, 1993.
37. Pine, R., Canova, A., and Schindler, C., Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene, EMBO J., 13, 158, 1994.
38. Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., Pellegrini, S., Wiks, A. F., Ihle, J. N., Stark, G. R., and Kerr, I. M., The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction, Nature, 366, 129, 1993.
39. Chang, R. J. and Lee, S. H., Effects of interferon-γ and tumor necrosis factor-α on the expression of an Iα antigen on a murine macrophage cell line, J. Immunol., 137, 2853, 1986.
40. Pfizenmaier, K., Scheurich, P., Schlüter, C., and Krönke, M., Tumor necrosis factor enhances HLA-A,B,C, and HLA-DR gene expression in human tumor cells, J. Immunol., 138, 975, 1987.
41. Arenzana-Seisdedos, A., Mogensen, S. C., Vuillier, F., Fiers, W., and Virelizier, J. L., Autocrine secretion of tumor necrosis factor under the influence of interferon-γ amplifies HLA-DR gene induction in human monocytes, Proc. Natl. Acad. Sci. U.S.A., 85, 6087, 1988.
42. Pujol-Borrell, R., Todd, I., Doshi, M., Bottazzo, G. F., Sutton, R., Gray, D., Adolf, G. R., and Feldmann, M., HLA class II induction in human islet cells by interferon-γ plus tumor necrosis factor or lymphotoxin, Nature, 326, 304, 1987.
43. Wright, J. R. Jr., Epstein, H. R., Hauptfeld, V., and Lacy, P. E., Tumor necrosis factor enhances interferon-induced Ia antigen expression on murine islet parenchymal cells, Am. J. Pathol., 130, 427, 1988.
44. Panek, R. B., Moses, H., Ting, J. P.-Y., and Benveniste, E. N., Tumor necrosis factor α response elements in the HLA-DRA promoter: identification of a tumor necrosis factor α-induced DNA-protein complex in astrocytes, Proc. Natl. Acad. Sci. U.S.A., 89, 11518, 1992.
45. Panek, R. B., Lee, Y.-J., Lindstrom-Itoh, Y., Ting, J. P.-Y., and Benveniste, E. N., Characterization of astrocyte nuclear proteins involved in IFN-γ and TNF-α mediated class II MHC gene expression, J. Immunol., 153, 4555, 1994.
46. Wedgwood, J. F., Hatam, L., and Bonagura, V. R., Effect of interferon-γ and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells, Cell. Immunol., 111, 1, 1988.
47. 2 and corticosterone on induced Ia expression on murine macrophages, J. Immunol., 145, 1167, 1990.
48. Wynn, T. A., Freund, Y. R., and Paulnock, D. M., TNF-α differentially regulates Ia antigen expression and macrophage tumoricidal activity in two murine macrophage cell lines, Cell. Immunol., 140, 184, 1992.
49. Melhus, O., Koerner, T. J., and Adams, D. O., Effects of TNF-α on the expression of class II MHC molecules in macrophages induced by IFNγ: evidence for suppression at the level of transcription, J. Leukocyte Biol., 49, 21, 1991.
50. Panek, R. B. and Benveniste, E. N., Class II MHC gene expression in microglia: regulation by the cytokines IFN-γ, TNF-α and TGF-β, J. Immunol., 154, 2846, 1995.
51. Watanabe, Y. and Jacob, C. O., Regulation of MHC class II antigen expression, J. Immunol., 146, 899, 1991.
52. Willman, C. L., Stewart, C. C., Miller, V., Yi, T.-L., and Tomasi, T. B., Regulation of MHC class II gene expression in macrophages by hematopoietic colony-stimulating factors (CSF), J. Exp. Med., 170, 1559, 1989.
53. Gosselin, E. J., Wardwell, K., Rigby, W. F. C., and Guyre, P. M., Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-γ, and IL-3, J. Immunol., 151, 1482, 1993.
54. Imamura, K., Suzumura, A., Sawada, M., Mabuchi, C., and Marunouchi, T., Induction of MHC class II antigen expression on murine microglia by interleukin-3, J. Neuroimmunol., 55, 119, 1994.
55. Massa, P. T., Dorries, R., and ter Meulen, V., Viral particles induce Ia antigen expression on astrocytes, Nature, 320, 543, 1986.
56. Suzumura, A., Lavi, E., Bhat, S., Murasko, D., Weiss, S. R., and Silberberg, D. H., Induction of glial cell MHC antigen expression in neurotropic coronavirus infections, J. Immunol., 140, 2068, 1988.
57. Hu, K. Q., Vierling, J. M., and Siddiqui, A., Transactivation of HLA-DR gene by hepatitis B virus X gene product, Proc. Natl. Acad. Sci., 87, 7140, 1990.
58. Suzumura, A., Sawada, M., Yamamoto, H., and Marunouchi, T., Transforming growth factor-β suppresses activation and proliferation of microglia in vitro, J. Immunol., 151, 2150, 1993.
59. Zuber, P., Kuppner, M. C., and de Tribolet, N., Transforming growth factor-β2 down-regulates HLA-DR antigen expression on human malignant glioma cells, Eur. J. Immunol., 18, 1623, 1988.
60. 1, modulates the expression of class II histocompatibility antigens on human cells, J. Immunol., 140, 4217, 1988.
61. Hong, L., Johannsen, L., and Krueger, J. M., Modulation of human leukocyte antigen DR expression in glioblastoma cells by interferon gamma and other cytokines, J. Neuroimmunol., 35, 139, 1991.
62. 1, repression of the HLA-DRα gene is mediated by conserved proximal promoter elements, J. Immunol., 151, 4173, 1993.
63. Panek, R. B., Lee, Y.-J., and Benveniste, E. N., TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2 or STAT1α or modification of IFNEX expression, J. Immunol., 154, 610, 1995.
64. Inaba, K., Kitaura, M., Kato, T., Watanabe, Y., Kawade, Y., and Muramatsu, S., Contrasting effects of alpha/beta and gamma-interferons on expression of macrophage Ia antigens, J. Exp. Med., 163, 1030, 1986.
65. Ling, P. D., Warren, M. K., and Vogel, S. N., Antagonistic effect of interferon-β on the interferon-γ-induced expression of Ia antigen in murine macrophages, J. Immunol., 135, 1857, 1985.
66. Fertsch-Ruggio, D., Schoenberg, D. R., and Vogel, S. N., Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-α/β and dexamethasone are regulated transcriptionally, J. Immunol., 141, 1582, 1988.
67. Devajyothi, C., Kalvakolanu, I., Babcock, G. T., Vasavada, H. A., Howe, P. H., and Ransohoff, R. M., Inhibition of interferon-γ-induced major histocompatibility complex class II gene transcription by interferon-β and type β1 transforming growth factor in human astrocytoma cells: definition of cis-element, J. Biol. Chem., 268, 18794, 1993.
68. Lu, H.-T., Riley, J. L., Babcock, G. T., Huston, M., Stark, G. R., Boss, J. M., and Ransohoff, R. M., Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ, J. Exp. Med., 182, 1517, 1995.
69. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M.-G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and de Vries, J. E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression, J. Exp. Med., 174, 915, 1991.
70. Macatonia, S. E., Doherty, T. M., Knight, S. C., and O'Garra, A., Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production, J. Immunol., 150, 3755, 1993.
71. Frei, K., Lins, H., Schwerdel, C., and Fontana, A., Antigen presentation in the central nervous system: the inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed, J. Immunol., 152, 2720, 1994.
72. Shrikant, P., Weber, E., Jilling, T., and Benveniste, E. N., ICAM-1 gene expression by glial cells: differential mechanisms of inhibition by interleukin-10 and interleukin-6, J. Immunol., 155, 1489, 1995.
73. Willems, F., Marchant, A., Delville, J.-P., Gérard, C., Delvaux, A., Velu, T., de Boer, M., and Goldman, M., Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes, Eur. J. Immunol., 24, 1007, 1994.
74. Lee, S. C., Liu, W., Roth, P., Dickson, D. W., Berman, J. W., and Brosnan, C. F., Macrophage colony-stimulating factor in human fetal astrocytes and microglia: differential regulation by cytokines and lipopolysaccharides, and modulation of class II MHC on microglia, J. Immunol., 150, 594, 1993.
75. Golde, D.W. and Gasson, J. C., Hormones that stimulate the growth of blood cells, Sci. Am., July, 62, 1988.
76. Murphy, S., Simmons, M. L., Agullo, L., Garcia, A., Feinstein, D. L., Galea, E., Reis, D. J., Minc-Golomb, D., and Schwartz, J. P., Synthesis of nitric oxide in CNS glial cells, TINS, 16, 323, 1993.
77. Heuschling, P., Nitric oxide modulates γ-interferon-induced MHC class II antigen expression on rat astrocytes, J. Neuroimmunol., 57, 63, 1995.
78. Sicher, S. C., Vazquez, M. A., and Lu, C. Y., Inhibition of macrophage Ia expression by nitric oxide, J. Immunol., 153, 1293, 1994.
79. Lee, S. C., Collins, M., Vanguri, P., and Shin, M. L., Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia, J. Immunol., 148, 3391, 1992.
80. Sicher, S. C., Chung, G. W., Vazquez, M. A., and Lu, C. Y., Augmentation or inhibition of IFN-γ-induced MHC class II expression by lipopolysaccharides, J. Immunol., 155, 5826, 1995.
81. Figueiredo, F., Uhing, R. J., Okonogi, K., Gettys, T. W., Johnson, S. P., Adams, D. O., and Prpic, V., Activation of the cAMP cascade inhibits an early event involved in murine macrophage Ia expression, J. Biol. Chem., 265, 12317, 1990.
82. Ivashkiv, L. B. and Glimcher, L. H., Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements, J. Exp. Med., 174, 1583, 1991.
83. Ivashkiv, L. B., Ayres, A., and Glimcher, L. H., Inhibition of IFN-γ induction of class II MHC genes by cAMP and prostaglandins, Immunopharmacology, 27, 67, 1994.
84. 2-adrenergic signal transduction mechanisms, Proc. Natl. Acad. Sci. U.S.A., 85, 1292, 1988.
85. Frohman, E. M., Frohman, T. C., Vayuvegula, B., Gupta, S., and van den Noort, S., Vasoactive intestinal polypeptide inhibits the expression of the MHC class II antigens on astrocytes, J. Neurol. Sci., 88, 339, 1988.
86. Basta, P. V., Moore, T. L., Yokota, S., and Ting, J. P. Y., A β-adrenergic agonist modulates DRα gene transcription via enhanced cAMP levels in a glioblastoma multiforme line, J. Immunol., 142, 2895, 1989.
87. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C., and Mathis, D., Mice lacking MHC class II molecules, Cell, 66, 1051, 1991.
88. + T cells in major histocompatibility complex class II-deficient mice, Science, 253, 1417, 1991.
89. Thompson, C. B., Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation?, Cell, 81, 979, 1995.
90. Bluestone, J. A., New perspectives of CD28-B7-mediated T cell costimulation, Immunity, 2, 555, 1995.
91. Scholl, P. R. and Geha, R. S., MHC class II signaling in B-cell activation, Immunol. Today, 15, 418, 1994.
92. Wade, W. F., Davoust, J., Salamero, J., André, P., Watts, T. H., and Cambier, J. C., Structural compartmentalization of MHC class II signaling function, Immunol. Today, 14, 539, 1993.
93. Cambier, J. C. and Lehmann, K. R., Ia-mediated signal transduction leads to proliferation of primed B lymphocytes, J. Exp. Med., 170, 877, 1989.
94. Fuleihan, R., Mourad, W., Geha, R. S., and Chatila, T., Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells, J. Immunol., 146, 1661, 1991.
95. Trede, N. S., Geha, R. S., and Chatila, T., Transcriptional activation of IL-1β and tumor necrosis factor-α genes by MHC class II ligands, J. Immunol., 146, 2310, 1991.
96. Mourad, W., Mehindate, K., Schall, T. J., and McColl, S. R., Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes, J. Exp. Med., 175, 613, 1992.
97. Hauschildt, S., Bessler, W. G., and Scheipers, P., Engagement of MHC class II molecules leads to nitrite production in bone marrow-derived macrophages, Eur. J. Immunol., 23, 2988, 1993.
98. Al-Daccak, R., Mehindate, K., Hèbert, J., Rink, L., Mecheri, S., and Mourad, W., Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line, Infect. Immun., 62, 2409, 1994.
99. Mehindate, K., Thibodeau, J., Dohlsten, M., Kalland, T., Sékaly, R.-P., and Mourad, W., Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression, J. Exp. Med., 182, 1573, 1995.
100. Mourad, W., Geha, R. S., and Chatila, T., Engagement of MHC class II molecules induces sustained lymphocyte function-associated molecule 1-dependent cell adhesion, J. Exp. Med., 172, 1513, 1990.
101. Fuleihan, R., Spertini, F., Geha, R. S., and Chatila, T., Role of protein kinase activation in the induction of B cell adhesion by MHC class II ligands, J. Immunol., 149, 1853, 1992.
102. Kansas, G. S., Cambier, J. C., and Tedder, T. F., CD4 binding to MHC class II antigens induces LFA-1-dependent and -independent homotypic adhesion of B lymphocytes, Eur. J. Immunol., 22, 147, 1992.
103. Kansas, G. S. and Tedder, T. F., Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and -independent adhesion in human B cells through a tyrosine kinase-dependent pathway, J. Immunol., 147, 4094, 1991.
104. Nabavi, N., Freeman, G. J., Gault, A., Godfrey, D., Nadler, L. M., and Glimcher, L. H., Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression, Nature, 360, 266, 1992.
105. Watts, T. H., Alaverdi, N.,Wade, W. F., and Linsley, P. S., Induction of costimulatory molecule B7 in M12 B lymphomas by cAMP or MHC-restricted T cell interaction, J. Immunol., 150, 2192, 1993.
106. Newell, M. K., VanderWall, J., Beard, K. S., and Freed, J. H., Ligation of MHC class II molecules mediates apoptotic cell death in resting B lymphocytes, Proc. Natl. Acad. Sci. U.S.A., 90, 10459, 1993.
107. Eichhorn, M., Prospero, T. D., Heussler, V. T., and Dobbelaere, D. A. E., Antibodies against MHC class II antigens directly inhibit the growth of T cells infected with Theileria parva without affecting their state of activation, J. Exp. Med., 178, 769, 1993.
108. Cambier, J. C., Newell, M. K., Justement, L. B., McGuire, J. C., Leach, K. L., and Chen, Z. Z., Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes, Nature, 327, 629, 1987.
109. Lane, P. J. L., McConnell, F. M., Schieven, G. L., Clark, E. A., and Ledbetter, J. A., The role of class II molecules in human B cell activation, J. Immunol., 144, 3684, 1990.
110. Scholl, P. R., Trede, N., Chatila, T. A., and Geha, R. S., Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1, J. Immunol., 148, 2237, 1992.
111. Matsuyama, S., Koide, Y., and Yoshida, T. O., HLA class II molecule-mediated signal transduction mechanism responsible for the expression of interleukin-1β and tumor necrosis factor-α genes induced by a staphylococcal superantigen, Eur. J. Immunol., 23, 3194, 1993.
112. Mooney, N. A., Brick-Ghannam, C., Ju, L., and Charron, D. J., Bacterial superantigens signaling via HLA class II on human B lymphocytes, Mol. Immunol., 31, 675, 1994.
113. Palkama, T. and Hurme, M., Signal transduction mechanisms of HLA-DR-mediated interleukin-1β production in human monocytes. Role of protein kinase C and tyrosine kinase activation, Hum. Immunol., 36, 259, 1993.
114. Morio, T., Geha, R. S., and Chatila, T. A., Engagement of MHC class II molecules by staphylococcal superantigens activates src-type protein tyrosine kinases, Eur. J. Immunol., 24, 651, 1994.
115. α chain of MHC class II molecules results in inefficient antigen presentation to antigen-specific T cells, Inter. Immunol., 6, 1467, 1994.
116. St. Pierre, Y. and Watts, T. H., Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells, J. Immunol., 147, 2875, 1991.
117. de Preval, C., Hadam, M. R., and Mach, B., Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency, N. Engl. J. Med., 318, 1295, 1988.
118. Benichou, B. and Strominger, J. L., Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis, Proc. Natl. Acad. Sci. U.S.A., 88, 4285, 1991.
119. Abdulkadir, S. A. and Ono, S. J., How are class II MHC genes turned on and off?, FASEB J., 9, 1429, 1995.
120. Sloan, J. H., Hasegawa, S. L., and Boss, J. M., Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes, J. Immunol., 148, 2591, 1992.
121. Cogswell, J. P., Austin, J., and Ting, J. P.-Y., The W element is a positive regulator of HLA-DRA transcription in various DR+ cell types, J. Immunol., 146, 1361, 1991.
122. Freund, Y. R., Dedrick, R. L., and Jones, P. P., cis-acting sequences required for class II gene regulation by interferon γ and tumor necrosis factor α in a murine macrophage cell line, J. Exp. Med., 171, 1283, 1990.
123. Tsang, S. Y., Mikiye, N., and Peterlin, B. M., B-cell-specific and interferon-γ-inducible regulation of the HLA-DRα gene, Proc. Natl. Acad. Sci. U.S.A., 85, 8598, 1988.
124. Tsang, S. Y., Nakanishi, M., and Peterlin, B. M., Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors, Mol. Cell. Biol., 10, 711, 1990.
125. Moses, H., Panek, R. B., Benveniste, E. N., and Ting, J. P.-Y., Usage of primary cells to delineate IFN-γ responsive DNA elements in the HLA-DRA promoter and to identify a novel IFN-γ enhanced nuclear factor, J. Immunol., 148, 3643, 1992.
126. Cogswell, J. P., Basta, P. V., and Ting, J. P.-Y., X-box-binding proteins positively and negatively regulate transcription of the HLA-DRA gene through interaction with discrete upstream W and V elements, Proc. Natl. Acad. Sci. U.S.A., 87, 7703, 1990.
127. Sugawara, M., Ponath, P. D., Sin, J., Yang, Z., and Strominger, J. L., Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression, Proc. Natl. Acad. Sci. U.S.A., 88, 10347, 1991.
128. Sugawara, M., Scholl, T., Ponath, P. D., and Strominger, J. L., A factor that regulates the class II major histocompatibility complex gene DPA is a member of a subfamily of zinc finger proteins that includes a Drosophila developmental control protein, Mol. Cell. Biol., 14, 8438, 1994.
129. Voliva, C. F., Aronheim, A., Walker, M. D., and Peterlin, B. M., B-cell factor 1 is required for optimal expression of the DRA promoter in B cells, Mol. Cell. Biol., 12, 2383, 1992.
130. Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M. R., Mach, B., and Reith, W., A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome), Genes Dev., 9, 1021, 1995.
131. Reith, W., Satola, S., Sanchez, C. H., Amaldi, I., Lisowska-Grospierre, B., Griscelli, C., Hadam, M. R., and Mach, B., Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein. RF-X, Cell, 53, 897, 1988.
132. Durand, B., Kobr, M., Reith, W., and Mach, B., Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX, Mol. Cell. Biol., 14, 6839, 1994.
133. Sanchez, C. H., Reith, W., Silacci, P. and Mach, B., The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters, Mol. Cell. Biol., 12, 4076, 1992.
134. Reith, W., Ucla, C., Barras, E., Gaud, A., Durand, B., Herrera-Sanchez, C., Kobr, M., and Mach, B., RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins, Mol. Cell. Biol., 14, 1230, 1994.
135. Itoh-Lindstrom, Y., Peterlin, B. M., and Ting, J. P.-Y., Affinity enrichment and functional characterization of TRAX1, a novel transcription activator and X1-sequence-binding protein of HLA-DRA, Mol. Cell. Biol., 15, 282, 1995.
136. Jabrane-Ferrat, N. and Peterlin, B. M., Ets-1 activates the DRA promoter in B cells, Mol. Cell. Biol., 14, 7314, 1994.
137. Song, Z., Krishna, S., Thanos, D., Strominger, J. L., and Ono, S. J., A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional represser, J. Exp. Med., 180, 1763, 1994.
138. Liou, H.-C., Boothby, M. R., Finn, P. W., Davidon, R., Nabavi, N., Zelenznik-Le, N. J., Ting, J. P.-Y., and Glimcher, L. H., A new member of the leucine zipper class of proteins that binds to the HLA-DRα promoter, Science, 247, 1581, 1990.
139. Ono, S. J., Bazil, V., Levi, B.-Z., Ozato, K., and Strominger, J. L., Transcription of a subset of human class II major histocompatibility complex genes is regulated by a nucleoprotein complex that contains c-fos or an antigenically related protein, Proc. Natl. Acad. Sci. U.S.A., 88, 4304, 1991.
140. Ono, S. J., Liou, H.-C., Davidon, R., Strominger, J. L., and Glimcher, L. H., Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos, Proc. Natl. Acad. Sci. U.S.A., 88, 4309, 1991.
141. Kara, C. J., Liou, H.-C., Ivashkiv, L. B., and Glimcher, L. H., A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain, Mol. Cell. Biol., 10, 1347, 1990.
142. Liou, H. C., Boothby, M. R., and Glimcher, L. H., Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element, Science, 242, 69, 1988.
143. Ivashkiv, L. B., Liou, H.-C., Kara, C. J., Lamph, W. W., Verma, I. M., and Glimcher, L. H., mXBP/ CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-0-tetradecanoyl-phorbol-13-acetate, response element, Mol. Cell. Biol., 10, 1609, 1990.
144. Andersson, G. and Peterlin, B. M., NF-X2 that binds to the DRA X2-box is activator protein 1, J. Immunol., 145, 3456, 1990.
145. Hasegawa, S. L. and Boss, J. M., Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters, Nucleic Acids Res., 19, 6269, 1991.
146. Moreno, C. S., Emery, P., West, J. E., Durand, B., Reith, W., Mach, B., and Boss, J. M., Purified X2 binding protein (X2BP) cooperatively binds the class IIMHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome, J. Immunol., 155, 4313, 1995.
147. Vilen, B. J., Cogswell, J. P., and Ting, J. P.-Y., Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function, Mol. Cell. Biol., 11, 2406, 1991.
148. Vilen, B. J., Penta, J. F., and Ting, J. P.-Y., Structural constraints within a trimeric transcriptional regulatory region: constitutive and interferon-γ-inducible expression of the HLA-DRA gene, J. Biol. Chem., 267, 23728, 1992.
149. Wright, K. L., Vilen, B. J., Itoh-Lindstrom, Y., Moore, T. L., Li, G., Criscitiello, M., Cogswell, P., Clarke, J. B., and Ting, J. P.-Y., CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors, EMBO J., 13, 4042, 1994.
150. Zeleznik-Le, N. J., Azizkhan, J. C., and Ting, J. P.-Y., Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene, Proc. Natl. Acad. Sci. U.S.A., 88, 1873, 1991.
151. Mantovani, R., Pessara, U., Tronche, F., Li, X.-Y., Knapp, A.-M., Pasquali, J.-L., Benoist, C., and Mathis, D., Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription, EMBO J., 11, 3315, 1992.
152. Didier, D. K., Woulfe, S. L., and Schwartz, B. D., Characterization of a DNA-binding protein system which is inversely correlated with class II expression, Immunol. Res., 9, 69, 1990.
153. Ting, J. P.-Y., Painter, A., Zeleznik-Le, N. J., MacDonald, G., Moore, T. M., Brown, A., and Schwartz, B. D., YB-1 DNA-binding protein represses interferon γ activation of class II major histocompatibility complex genes, J. Exp. Med., 179, 1605, 1994.
154. Sherman, P. A., Basta, P. V., and Ting, J. P.-Y., Upstream DNA sequences required for tissue-specific expression of the HLA-DRα gene, Proc. Natl. Acad. Sci. U.S.A., 84, 4254, 1987.
155. Miwa, K., Doyle, C., and Strominger, J. L., Sequence-specific interactions of nuclear factors with conserved sequences of human class II major histocompatibility complex genes, Proc. Natl. Acad. Sci. U.S.A., 84, 4939, 1987.
156. Miwa, K. and Strominger, J. L., The HLA-DQb gene upstream region contains an immunoglobulin-like octamer motif that binds cell-type specific nuclear factors, Nucleic Acids Res., 15, 8057, 1987.
157. Sherman, P. A., Basta, P. V., Moore, T. L., Brown, A. M., and Ting, J. P.-Y., Class II box consensus sequences in the HLA-DRα gene: transcriptional function and interaction with nuclear proteins, Mol. Cell. Biol., 9, 50, 1989.
158. Abdulkadir, S. A., Krishna, S., Thanos, D., Maniatis, T., Strominger, J. L., and Ono, S. J., Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression, J. Exp. Med., 182, 487, 1995.
159. Albert, S. E., Strutz, F., Shelton, K., Haverty, T., Sun, M. J., Li, S., Denham, A., Maki, R. A., and Neilson, E. G., Characterization of a cis-acting regulatory element which silences expression of the class II A β gene in epithelium, J. Exp. Med., 180, 233, 1994.
160. Boss, J. M. and Strominger, J. L., Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts, Proc. Natl. Acad. Sci. U.S.A., 83, 9139, 1986.
161. Hehlgans, T. and Strominger, J. L., Activation of transcription by binding of NF-E1 (YY1) to a newly identified element in the first exon of the human DRα gene, J. Immunol., 154, 5181, 1995.
162. Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., and Mach, B., Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA, Science, 265, 106, 1994.
163. Chang, C.-H., Fontes, J. D., Peterlin, M., and Flavell, R. A., Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes, J. Exp. Med., 180, 1367, 1994.
164. Chin, K.-C., Mao, C., Skinner, C., Riley, J. L., Wright, K. L., Moreno, C. S., Stark, G. R., Boss, J. M., and Ting, J. P.-Y., Molecular analysis of G1B and G3A IFNγ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction, Immunity, 1, 687, 1994.
165. Riley, J. L., Westerheide, S. D., Price, J. A., Brown, J. A., and Boss, J. M., Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA), Immunity, 2, 533, 1995.
166. Zhou, H. and Glimcher, L. H., Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency, Immunity, 2, 545, 1995.
167. Riley, J. L. and Boss, J. M., Class II MHC transcriptional mutants are defective in higher order complex formation, J. Immunol., 151, 6942, 1993.
168. Reith, W., Siegrist, C.-A., Durand, B., Barras, E., and Mach, B., Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y, Proc. Natl. Acad. Sci. U.S.A., 91, 554, 1994.
169. Reith, W., Kobr, M., Emery, P., Durand, B., Siegrist, C.-A., and Mach, B., Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters, J. Biol. Chem., 269, 20020, 1994.
170. Thanos, D. and Maniatis, T., The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell, 71, 777, 1992.
171. Meraz, M., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., and Schreiber, R. D., Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway, Cell, 84, 431, 1996.
172. Chang, C.-H., Guerder, S., Hong, S.-C., van Ewijk, W., and Flavell, R. A., Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression, Immunity, 4, 167, 1996.